Earnings Miss
1HFY2025 Core Net Profit: RM7.1m
After adjustments (NRV write-down + onerous provision of RM22m).
Only 29% of full-year forecast achieved, well below expectations.
Key Issue: Earnings miss reflects weaker ASPs and thinner margins.
Analyst Downgrades
BIMB Securities Research:
Cut rating from Neutral to Sell.
Slashed earnings forecasts:
FY2025: -48%
FY2026: -68%
FY2027: -72%
Cited Thai sugar dumping risk after China banned liquid sugar imports, putting pressure on ASPs.
MBSB Research:
Downgraded from Neutral to Sell.
Expects recovery delayed to FY2026 instead of FY2025.
Pegged lower TP of RM0.71 (vs current price RM0.98).
Warned of price war among AP players with excess inventory.
Market Reaction
Shares fell 1.5% to RM0.98 (Aug 26).
YTD performance: -19%.
MSM is one of only two refiners in Malaysia (the other is unlisted Central Sugars Refinery under Syed Mokhtar).
Sector & Macro Headwinds
Supply glut: Abundant production from top 3 global sugar exporters driving down NY11 prices.
FX risks: Volatility adds pressure to import-heavy refiners.
China factor: Ban on liquid sugar imports diverts Thai supply into Malaysia and regional markets.
Margins squeezed: Industrial & export segments face narrowing ASP premium.
Investor Takeaways
Structural challenges: MSM’s recovery story is undermined by global oversupply, Thai dumping risk, and currency volatility.
Valuation pressure: With earnings forecast cuts up to 72% by FY2027, the downgrade cycle may weigh further on share price.
Dividend outlook: Payout sustainability in question if earnings continue to underperform.
Long-term play? Turnaround may hinge on regulatory intervention (anti-dumping measures, pricing framework) or demand recovery.
Conclusion: MSM’s short-to-medium term outlook is bearish. Investors should treat it as a high-risk turnaround bet with significant downside until sector dynamics stabilize.
Comments
Post a Comment